share_log

藥明生物：翌日披露報表

WUXI BIO: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 22 08:53
Summary by Moomoo AI
药明生物技术有限公司於2024年4月22日提交了翌日披露報表，披露了自2023年12月7日至2024年4月22日期間的股份購回活動。該公司在此期間進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年4月22日，當日購回了1,550,000股，佔已發行股份的0.03721%。購回的股份以每股12.94港元至12.78港元的價格進行，總計購回金額為19,912,150港元。根據報表，药明生物確認所有購回均按照香港聯合交易所有限公司主板上市規則進行，並無重大變動。此外，自普通決議案通過以來，公司在香港聯交所購回的證券總數為94,707,000股，佔已發行股份的2.22923%。
药明生物技术有限公司於2024年4月22日提交了翌日披露報表，披露了自2023年12月7日至2024年4月22日期間的股份購回活動。該公司在此期間進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年4月22日，當日購回了1,550,000股，佔已發行股份的0.03721%。購回的股份以每股12.94港元至12.78港元的價格進行，總計購回金額為19,912,150港元。根據報表，药明生物確認所有購回均按照香港聯合交易所有限公司主板上市規則進行，並無重大變動。此外，自普通決議案通過以來，公司在香港聯交所購回的證券總數為94,707,000股，佔已發行股份的2.22923%。
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 22, 2024 DISCLOSING SHARE REPURCHASE ACTIVITIES FOR THE PERIOD FROM DECEMBER 7, 2023 TO APRIL 22, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on April 22, 2024, and on that day 1,550,000 shares were repurchased, representing 0.03721% of the issued shares. The repurchased shares were made at a price of HK$12.94 to HK$12.78 per share, for a total repurchase amount of HK$19,912,150. According to the report, DMA confirmed that all repurchases were made in accordance with the listing rules of the Main Board of the Hong Kong Stock Exchange Limited without significant changes. In addition, since the adoption of the Ordinary Resolution, the Company has repurchased 94,707,000 shares on the Hong Kong Stock Exchange, representing 2.22923% of the issued shares.
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 22, 2024 DISCLOSING SHARE REPURCHASE ACTIVITIES FOR THE PERIOD FROM DECEMBER 7, 2023 TO APRIL 22, 2024. The company has made several share repurchases during this period, but has not written them off. The last repurchase took place on April 22, 2024, and on that day 1,550,000 shares were repurchased, representing 0.03721% of the issued shares. The repurchased shares were made at a price of HK$12.94 to HK$12.78 per share, for a total repurchase amount of HK$19,912,150. According to the report, DMA confirmed that all repurchases were made in accordance with the listing rules of the Main Board of the Hong Kong Stock Exchange Limited without significant changes. In addition, since the adoption of the Ordinary Resolution, the Company has repurchased 94,707,000 shares on the Hong Kong Stock Exchange, representing 2.22923% of the issued shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more